D.E. Shaw & Co
ARVN icon

D.E. Shaw & Co’s Arvinas ARVN Stock Holding History

D.E. Shaw & Co’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29M Sell
3,495,153
-143,414
-4% -$1.34M 0.01% 1056
2026
Q1 		$38.6M Sell
3,638,567
-50,634
-1% -$627K 0.02% 779
2025
Q4 		$43.8M Buy
3,689,201
+342,038
+10% +$3.73M 0.02% 776
2025
Q3 		$28.5M Buy
3,347,163
+1,196,433
+56% +$9.07M 0.02% 941
2025
Q2 		$15.8M Buy
+2,150,730
New +$15.8M 0.01% 1183
2024
Q4 		– Sell
-37,124
Closed -$914K – 4396
2024
Q3 		$914K Sell
37,124
-187,227
-83% -$4.89M ﹤0.01% 3341
2024
Q2 		$5.97M Sell
224,351
-79,287
-26% -$2.53M 0.01% 1720
2024
Q1 		$12.5M Buy
303,638
+218,707
+258% +$9.56M 0.01% 1229
2023
Q4 		$3.5M Buy
84,931
+64,131
+308% +$1.5M ﹤0.01% 2209
2023
Q3 		$409K Buy
+20,800
New +$510K ﹤0.01% 3501
2022
Q4 		– Sell
-6,377
Closed -$284K – 4847
2022
Q3 		$284K Sell
6,377
-7,060
-53% -$343K ﹤0.01% 4322
2022
Q2 		$566K Sell
13,437
-6,728
-33% -$338K ﹤0.01% 4022
2022
Q1 		$1.36M Sell
20,165
-40,953
-67% -$2.79M ﹤0.01% 3656
2021
Q4 		$5.02M Sell
61,118
-94,531
-61% -$7.69M ﹤0.01% 2373
2021
Q3 		$12.8M Buy
155,649
+41,392
+36% +$3.66M 0.01% 1327
2021
Q2 		$8.8M Sell
114,257
-23,065
-17% -$1.6M 0.01% 1599
2021
Q1 		$9.08M Buy
137,322
+67,964
+98% +$5.2M 0.01% 1425
2020
Q4 		$5.89M Sell
69,358
-5,913
-8% -$204K 0.01% 1752
2020
Q3 		$1.78M Sell
75,271
-84,112
-53% -$2.44M ﹤0.01% 2484
2020
Q2 		$5.35M Buy
159,383
+39,473
+33% +$1.68M 0.01% 1620
2020
Q1 		$4.83M Buy
119,910
+9,973
+9% +$466K 0.01% 1491
2019
Q4 		$4.52M Buy
+109,937
New +$3.22M 0.01% 1810

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

D.E. Shaw & Co's ARVN Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Arvinas (ARVN) stake by 3.9% in Q2 2026, selling an estimated $1.34M and leaving 3,495,153 shares worth $29M. The position accounts for 0.01% of the portfolio, ranked #1056.

D.E. Shaw & Co first reported a position in ARVN in Q4 2019 and has held it in 22 quarters since. The position peaked at $43.8M in Q4 2025. 200 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • D.E. Shaw & Co held 3,495,153 shares of Arvinas worth $29M as of Q2 2026.
  • D.E. Shaw & Co sold 143,414 Arvinas shares in Q2 2026, an estimated $1.34M.
  • Arvinas made up 0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #1056 holding.
  • D.E. Shaw & Co first reported a position in Arvinas in Q4 2019 and has held it in 22 quarters since.
  • D.E. Shaw & Co's Arvinas position peaked at $43.8M in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.